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Incidence and etiology : -
• About 1/100 live births.
• Sexes are equally affected
• Higher incidence of PDA and ASD in children born at high 
altitudes
• Maternal infection (Rubella) associated with PDA , 
Pulmonary valve/artery stenosis , ASD. 
• Maternal exposure to drugs and toxins (alcohol) associated 
with septal defects
Classificaion: -
Left to right side shunts (ASD,VSD,PDA)
Right to left shunts (Fallot,Tricuspid atresia, Ebstein anomaly)
Obstructive lessions (Aortic,pulmonary,tricuspid stenosis, aortic 
coartation,valvular regurgitation)
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Classificaion: -
With shunt  
acyanotic VSD,ASD,PDA; 
cyanotic (Fallot,tricuspid artesia,transposition of great vessels, 
truncus arteriosus,Ebstein anomaly,pulmonary atresia)
Without shunt
aortic, tricuspid and pulmonary stenosis
coarctation of aorta
valvular regurgitation 
Treatment strategy –on time diagnosis on time treatment to prevent  
heart failure
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Treatment of CHD
surgical                         interventional 
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Congenital heart diseases - treatment
Annual trend 2000-2012  N=618pts
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Type of procedure N- 618 pts
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Atrial septum defect n=130
• Not reccomanded in cases with
absent posteroinferior and 
anterosuperior rims
*ACC/AHA 2008 Guidelines for the Management of  
Congenital Heart Disease
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ASD  – results and follow up n=130pts 
 Patient followed by TTE/TEE and angio
 10-36mm ASD devices
 Failure to close in 4 pts (large   
ASD 2),  insufficient AS rim (2)
 In hospital stay 20±4 hours
 TEE in all adults
 1 boy with TEE in general anesthesia
 ASA 10mg/kgTT/day in next 6 months
 Clopidogrel 75mg/24h-adults
 6 months IE prophylaxis
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Pulmonary valve stenosis, n=57
Indication
Class I
Doppler gradient greater than 60 mm Hg (mean Doppler gradient > than 40 mm Hg) 
Class IIb
In dysplastic pulmonary valve Doppler gradient > 60 mm Hg (mean Doppler gradient greater than 40 mm Hg)  
In  symptomatic patients with a dysplastic pulmonary valve and peak gradient by Doppler > 50 mm Hg or a mean 
Doppler gradient greater than 30 mm Hg.  
*ACC/AHA 2008 Guidelines for the Management of  Congenital Heart Disease
 Average reduction TVPG 54 ±
9mmHg
 14 pts were treated with B-
blockers after
 Young female surgical treated 
 A tamponade in neonatal form-
succesfully treated
 PR < 1 degree in all
 Long life prophylaxis IE
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PDA n=46 pts
Class I
Closure of a PDA either percutaneously or 
surgically is indicated for the following: 
Left atrial and/or LV enlargement or if PAH is 
present, or in the presence of net left-to-right 
shunting.
Prior endarteritis 
Contraindication:
calcified PDA. 
Class IIa
1 It is reasonable to close an asymptomatic small 
PDA by catheter device. 
2 PDA closure is reasonable for patients with PAH 
with a net left-to-right shunt. 
*ACC/AHA 2008 Guidelines for the Management of  
Congenital Heart Disease
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PDA results and follow up 46pts
 44/46 pts were closed without shunt
 One girl with small shunt (coil)
 23 Amplatz devices/ 23 coils were 
implanted
 In hospital stay 28 ± 4 h
 Boy referred for surgery- large PDA
 Surgical extirpation of device from 
femoral vein in one girl (OR in stand 
by)
 Prophylaxis of IE 3 months
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Balloon angioplasty, stenting of aorta n=18pts
 Balloon angioplasty, 13 pts
 Stenting of aorta in 5pts
Average reduction of PG  30 5 mmHg
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VSD- Amplatz perimembraneous
ocluder n=8pts
 8 pts with perimembranous VSD
 Aged 5 -45 y
 Child with trisomy 21 and VSD
 ECG without AV block
 Amplatz perimembraneous
occluder 8-14mm
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Congenital aortic stenosis- 7pts
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Closure of paravalvular leak- case report
 55 y.old female with MS, PAH, DM, 
obesity, HOBB, hypothireosis
Octomber, 2005 MVR (mechanical)
May, 2007 valve thrombosis, pulmonary 
edema, urgent re- do
Postoperative paravalvular leak 3 
degree
August 2007, closure of leak with 
implantation of muscular VSD 
occluder 8 mm
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Postsurgical VSD- case report
I surgery: 07.12.2001
Echo: PAH 
(PA syst/med 110/65)
MReg.+3, TReg +4,VSD, PA med42mm
Surgery: PA banding, MKR, TKR
PA- 29mm, PA syst/med 68/43
II-surgery 05.11.2004 
Echo: MReg.+4 (prolaps/dilation of ring), 
TReg.+3, PA syst/med 110/60, LAP 30
Surgery: replacement of mitral valve  ,ASD 
closure with pericardial patch
PA syst/med 60/23
01/2005 heart failure, new AV block
18.02/2005 permanent PM
18.08.2007 closure with Amplatzer device 
VSD 
Th: ACE inh, Spironolactone, diuretics, OAT
Follow up 11 years
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Conclussion
Interventional procedures are 
method of choice for treatment of 
congenital heart disease.
Less stres for patients with 
excellent permanent outcome
Surgery is final option when this 
procedures are not able to resolve 
the problem
